Brewers chairman and principal owner Mark Attanasio issued a statement late Saturday night offering the organization’s official stance on the allegations that left fielder Ryan Braun was using synthetic testosterone during the 2011 season.
If you’re not into reading prepared statements, which almost always lack provocativeness, the gist is this: Braun has been an honorable player since he was drafted in 2005 and his side of the story deserves to be heard before people begin to make judgements.
Via MLB.com, here are Attanasio’s words in full:
“Ryan Braun has been a model citizen in every sense of the word, both in the Milwaukee community and for the Brewers. Since joining our organization in 2005, he has been a person of character and integrity.
MLB has put a confidential testing program into place, which I personally support, that has a specific review process that must be followed before determining whether a player is in violation. Ryan has issued a statement that there are highly unusual circumstances surrounding this case that will support his complete innocence and demonstrate that there was absolutely no intentional violation of the program. We are dealing with an incomplete set of facts and speculation. Before there is a rush to judgement Ryan deserves the right to be heard. We are committed to supporting Ryan to get to the truth of what happened in this unfortunate situation.
As a father, I take the use of prohibited substances seriously, because I know the effects they can have on the body and on a person’s life. I want the Milwaukee community to know that we support drug testing not only because it is MLB policy but because it is the right thing to do.
I need to acknowledge that at this point the Milwaukee Brewers have not heard from the Office of the Commissioner or any official entity related to the MLB testing programs. Accordingly we do not have access to any of the facts or knowledge of any of the circumstances that are being circulated in the media with regard to Ryan Braun. The team will release follow-up statements at the appropriate time.”
Braun is claiming to be “completely innocent” and is currently in arbitration with MLB over the positive test.
The Associated Press is reporting that the Cubs and starter Jake Arrieta have avoided arbitration, agreeing to a $10.7 million salary for the 2016 season. That marks the highest salary on a one-year deal for a pitcher with four years of service, the AP notes. Arrieta and the Cubs were set to go before an independent arbitrator but now can simply focus on the season ahead.
Arrieta, 29, is in his second of three years of arbitration eligibility. He had filed for $13 million while the Cubs countered at $7.5 million. The $5.5 million gap was the largest among players who did not come to terms with their respective teams by the January deadline. The $10.7 million salary is $450,000 above the midpoint between the two submitted figures.
Arrieta won the National League Cy Young Award for his performance this past season, narrowly edging out Zack Greinke, then with the Dodgers. Arrieta led the majors with 22 wins, four complete games, and three shutouts. With that, he compiled a 1.77 ERA and a 236/48 K/BB ratio across 229 innings.
Once a top prospect in the Orioles’ minor league system, Arrieta struggled in the majors but found immediate success with the Cubs in 2013 after the O’s traded him along with Pedro Strop in exchange for Steve Clevenger and Scott Feldman.
Per Baseball America’s Matt Eddy, the Giants have signed infielder Conor Gillaspie to a minor league deal. Gillaspie was selected by the Giants in the supplemental round of the 2008 draft, then was traded to the White Sox in February 2013.
Gillaspie, 28, hit a meager .228/.269/.359 with four home runs and 24 RBI in 253 plate appearances between the White Sox and Angels during the 2015 season. Almost all of his playing time has come at third base but he can also play first base if needed.
The Giants, thin on depth, will allow Gillaspie to audition in spring training for a spot on the 25-man roster.
Jon Morosi of FOX Sports reports that free agent reliever Joe Nathan, recovering from Tommy John surgery, plans to pitch in 2016 according to his agent Dave Pepe. According to Pepe, Nathan’s workouts are “going well” and the right-hander is “definitely planning on playing this year.”
Nathan, 41, got the final out on Opening Day (April 6) against the Twins before going on the disabled list with a flexor strain in his right elbow, causing him to miss the next 161 games. He will likely be able to contribute out of the bullpen in late May or early June if he has no setbacks. On a minor league deal or incentive-laden major league deal, Nathan could make for a low-risk gamble.
Over a 15-season career that dates back to 1999 (he did not pitch in the majors in 2001 or 2010), Nathan has 377 saves with a 2.89 ERA and a 967/340 K/BB ratio over 917 innings.
On Thursday, we learned that the Diamondbacks were still considering free agent reliever Tyler Clippard. You can add the Rays to the list as well, per Marc Topkin of the Tampa Bay Times.
The Rays traded lefty reliever Jake McGee to the Rockies in exchange for outfielder Corey Dickerson in late January, so Clippard would be able to slot right in behind closer Brad Boxberger. Clippard, 30, compiled a 2.92 ERA with 64 strikeouts and 31 walks over 71 innings in a season split between the Athletics and Mets. The strikeout rate was at its lowest since the right-hander become a full-time reliever in 2009, and his walk rate was at its highest since 2010, which may be a factor in his still being a free agent in February.